Scientists at the University of Oxford have developed a new method to 3D-print laboratory-grown cells to form living structures.
The approach could revolutionise regenerative medicine, enabling the production of complex tissues and cartilage that would potentially support, repair or augment diseased and damaged areas of the body.
Printing high-resolution living tissues is hard to do, as the cells often move within printed structures and can collapse on themselves. But, led by Professor Hagan Bayley, Professor of Chemical Biology in Oxford’s Department of Chemistry, the team devised a way to produce tissues in self-contained cells that support the structures to keep their shape.
The cells were contained within protective nanolitre droplets wrapped in a lipid coating that could be assembled, layer-by-layer, into living structures. Producing printed tissues in this way improves the survival rate of the individual cells, and allowed the team to improve on current techniques by building each tissue one drop at a time to a more favourable resolution.
To be useful, artificial tissues need to be able to mimic the behaviours and functions of the human body. The method enables the fabrication of patterned cellular constructs, which, once fully grown, mimic or potentially enhance natural tissues.
Dr Alexander Graham, lead author and 3D Bioprinting Scientist at OxSyBio (Oxford Synthetic Biology), said: ‘We were aiming to fabricate three-dimensional living tissues that could display the basic behaviours and physiology found in natural organisms. To date, there are limited examples of printed tissues, which have the complex cellular architecture of native tissues. Hence, we focused on designing a high-resolution cell printing platform, from relatively inexpensive components, that could be used to reproducibly produce artificial tissues with appropriate complexity from a range of cells including stem cells’.
The researchers hope that, with further development, the materials could have a wide impact on healthcare worldwide. Potential applications include shaping reproducible human tissue models that could take away the need for clinical animal testing.
Over the coming months they will work to develop new complementary printing techniques, that allow the use of a wider range of living and hybrid materials, to produce tissues at industrial scale. Dr Sam Olof, Chief Technology Officer at OxSyBio, said: ‘There are many potential applications for bioprinting and we believe it will be possible to create personalised treatments by using cells sourced from patients to mimic or enhance natural tissue function. In the future, 3D bio-printed tissues maybe also be used for diagnostic applications – for example, for drug or toxin screening.’
Learn more: A new method of 3D printing living tissues
The Latest on: Regenerative medicine
- BRIEF-China Regenerative Medicine International Proposes To Raise Between About Hk$351.72 Mln & Hk$354.23 Mlnon November 28, 2019 at 4:02 pm
Nov 28 (Reuters) - China Regenerative Medicine International Ltd: * PROPOSES TO RAISE NOT LESS THAN HK$351.72 MILLION & NOT MORE THAN ABOUT HK$354.23 MILLION BY ISSUING OFFER SHARES * TO ISSUE BETWEEN ...
- Regenerative Medicine Market: Facts, Figures and Analytical Insights 2019-2024on November 28, 2019 at 1:48 am
Nov 28, 2019 (AmericaNewsHour) -- As stated by the research report published by Azoth Analytics in August 2019, the Global Regenerative Medicine Market was valued at USD 22,814.45 million the year ...
- Hitachi develops automation technology of 3D culture to expand regenerative medicine businesson November 27, 2019 at 9:29 pm
Furthermore the support service to establish an automatic manufacturing process for customers who are considering automation of manufacturing regenerative medicine products will be started on December ...
- Global Regenerative Medicine Market Analysis 2018-2019 with Forecasts to 2025 - ResearchAndMarkets.comon November 27, 2019 at 4:30 pm
The "Regenerative Medicine Market Size, Outlook and Growth Opportunities, 2019- 2025" report has been added to ResearchAndMarkets.com's offering. This report includes the latest predictions of the ...
- Hitachi Developed Automation Technology of 3D Culture to Expand Regenerative Medicine Businesson November 26, 2019 at 8:17 pm
A schematic diagram of automated new 3D culture*10 Furthermore the support service to establish an automatic manufacturing process for customers who are considering automation of manufacturing ...
- Regenerative Medicine Market Trends, Drivers, Strategies, Size, Demand, Growth, Applications and Competitive Landscape 2024on November 26, 2019 at 12:36 am
Nov 26, 2019 (The Expresswire) -- Regenerative Medicine Market 2019 Global Industry research report offers you market size, industry growth, share, development trends, product demand, investment plans ...
- AVITA Medical and the Gates Center for Regenerative Medicine at the University of Colorado Anschutz ...on November 24, 2019 at 2:45 pm
AVITA Medical (ASX: AVH, NASDAQ: RCEL), a regenerative medicine company with a technology platform positioned to address unmet medical needs in therapeutic skin restoration, and scientists at the ...
- Heartseed Raises $26M in Series B Funding to Accelerate Development of iPSC-derived Regenerative Medicine for Heart Failureon November 22, 2019 at 4:00 am
which has supported Heartseed from Series A. “I have been involved in the research of cardiac regenerative medicine for the past 20-years as a pioneer in this field and solved all the major challenges ...
- MEDIA ADVISORY: Advances in Regenerative Medicine through Exosome Therapy presented by Dr. Ducan Ross, founder of Kimera Labs at Perpetual Lifeon November 21, 2019 at 5:43 am
As a pioneer in the development of cell-free exosome products, Dr. Ross's research has been and continues to be employed by many physicians and clinics in a variety of regenerative medicine protocols.
- Did You Manage To Avoid China Regenerative Medicine International's (HKG:8158) 96% Share Price Wipe Out?on November 19, 2019 at 7:49 pm
Over the last month the China Regenerative Medicine International Limited (HKG:8158) has been much stronger than before, rebounding by 135%. But the last three years have seen a terrible decline. The ...
via Google News and Bing News